Back
AVITA Medical 10K Form
Sell
33
RCEL
AVITA Medical
Last Price:
$8.55
Seasonality Move:
-0.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCEL News And Ratings
See the #1 stock for the next 7 days that we like better than RCEL
RCEL Financial Statistics
Sales & Book Value
| Annual Sales: | $64.3M |
|---|---|
| Cash Flow: | $-9.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.17 |
| Price / Book: | 50.15 |
Profitability
| EPS (TTM): | -2.39000 |
|---|---|
| Net Income (TTM): | $-61.8M |
| Gross Margin: | $55.2M |
| Return on Equity: | -252.91% |
| Return on Assets: | -67.57% |
AVITA Medical Earnings Forecast
Key AVITA Medical Financial Ratios
-
The Gross Profit Margin over the past 21 years for RCEL is 85.85%.
-
The Selling, General & Administrative Expenses for RCEL have been equal to 142.24% of Gross Profit Margin.
-
The Research & Development expenses have been 31.69% of Revenue.
-
The Net Earning history of RCEL is -96.26% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 13 years.
AVITA Medical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RCEL |
| Website: | avitamedical.com |
Debt
| Debt-to-Equity Ratio: | 9.39 |
|---|---|
| Current Ratio: | 2.83 |
| Quick Ratio: | 2.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 16.49 |
RCEL Technical Analysis vs Fundamental Analysis
Sell
33
AVITA Medical (RCEL)
is a Sell
Is AVITA Medical a Buy or a Sell?
-
AVITA Medical stock is rated a SellThe current AVITA Medical [RCEL] share price is $8.56. The Score for RCEL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.